Sign up for the Austonia daily newsletter
×
becomeMemberIcon

become a member

(Giovanni Cancemi/Adobe)

Austin-based medical technology company Babson Diagnostics has received emergency use authorization from the Food & Drug Administration for its COVID-19 antibody test, the company announced Thursday.


Babson is one of five clinical labs to have received an EUA for an antibody test.

Such tests can help detect whether a person has been exposed to COVID-19 and developed antibodies in response.

The Babson test is currently the subject of clinical studies, including at Dell Medical School at the University of Texas at Austin.

Other companies—including local health care providers such as Total Men's Primary Care, Remedy and Victory Medical—have offered antibody testing for months, but FDA approval has been rare.

Researchers are still studying COVID-19 and have yet to answer questions about how long immunity to the virus may last. But the tests are also useful for identifying potential convalescent plasma donors, whose antibodies may help treat COVID-19 patients.

Babson plans to use its current antibody test as a building block, refining it as its researchers learn more about COVID-19 and its pathology.

Popular

A person who appeared to be leaving a minivan reportedly robbed East Austin's la Barbecue. (la Barbecue/Instagram)

East Austin restaurant la Barbecue has been robbed a third time in less than three months, according to a post on the restaurant's Instagram.

Keep Reading Show less

Giga Texas grabbed attention during Tesla's Q4 earnings call. The Austin factory is seen as pivotal to the company's growth going forward. (Tesla)

After 12 months, the long-anticipated massive Tesla factory in Southeast Travis County is up and operating and everyone wants a look inside.

Keep Reading Show less